Rolling forward its mid-term guidance with strong 2024 performance as the base year, Novartis now expects to grow sales at +5% CAGR 2024-2029. The company remains on track to deliver core operating ...

Acquisition of Kate Therapeutics enhances and strengthens Novartis strategic priorities in gene therapy and neuroscience innovation Transaction includes enabling technology platforms and therapeutic ...

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

Originally from Colombia, I trained as a Biologist and Microbiologist before moving to Brazil for academic research. After earning my Masters and starting a PhD in Neglected Tropical Diseases, I ...

Novartis has climbed three places to secure the top position in the 2024 Access to Medicine Index. The Access to Medicine Foundation (ATMI) report highlights Novartis' leading role in research and ...

At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...

“Contract” means the agreement between Novartis Pharma N.V. (“Novartis”) and the Client, which shall consist of the Order, these general sales terms (“Sales Terms”) and/ or other terms referred to in ...